BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, July 14, 2026
Home » Topics » Briefs » Appointments and advancements

Appointments and advancements
Appointments and advancements RSS Feed RSS

Appointments and advancements for June 14, 2024

June 14, 2024
New hires and promotions in the med-tech industry, including: Noom.
Read More

Appointments and advancements for June 13, 2024

June 13, 2024
New hires and promotions in the biopharma industry, including: Araris, Connect, Repligen, Voyager.
Read More

Appointments and advancements for June 13, 2024

June 13, 2024
New hires and promotions in the med-tech industry, including: Avation Medical, Eyenuk, Scibase.
Read More

Appointments and advancements for June 12, 2024

June 12, 2024
New hires and promotions in the biopharma industry, including: Alzheon, Neurona, Newcells, Nimble, Regenxbio, Treveni, T-Therapeutics, Vera, Zai Lab.
Read More

Appointments and advancements for June 12, 2024

June 12, 2024
New hires and promotions in the med-tech industry, including: Bonesupport.
Read More

Appointments and advancements for June 11, 2024

June 11, 2024
New hires and promotions in the biopharma industry, including: Adverum, Cantargia, Cybin, Pepgen, Quralis, Skyhawk, Thermosome.
Read More

Appointments and advancements for June 11, 2024

June 11, 2024
New hires and promotions in the med-tech industry, including: Axosim, Biosig, C2Sense, Cutera, Delphinus, Envoy Medical, GE Healthcare, Orthofix Medical.
Read More

Appointments and advancements for June 10, 2024

June 10, 2024
New hires and promotions in the biopharma industry, including: Biocartis, C4, Centessa, Cumulus Oncology, Galimedix, Macomics, Pyxis Oncology, Renovorx.
Read More

Appointments and advancements for June 10, 2024

June 10, 2024
New hires and promotions in the med-tech industry, including: Concertai, Seastar, Teledoc.
Read More

Appointments and advancements for June 7, 2024

June 7, 2024
New hires and promotions in the biopharma industry, including: Boston, Exscientia, Plus.
Read More
Previous 1 2 … 90 91 92 93 94 95 96 97 98 … 328 329 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 13, 2026.
  • Wainua autoinjector

    Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

    BioWorld
    News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • AI-generated  illustration of a neuron with tau protein aggregation

    AAIC 2026: Age of amyloid is being joined by time of tau

    BioWorld
    The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
  • NRF2 activators reported in Vailima Peninsula patent

    BioWorld Science
    Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing